PLA2R1 and membranous glomerulonephritis: In membranous nephropathy, another autoimmune kidney disease, longitudinal analysis of future clinical cases showed that 56% of the seropositive patients became seropositive for PLA2R autoantibodies ≤1 year before diagnosis (Figure 3C) (62).